NTT-DATA
26.2.2024 06:02:29 CET | Business Wire | Press release
NTT DATA, a global leader in IT infrastructure and services, and Schneider Electric, a pioneer in digital transformation for energy management and automation, have unveiled a first-of-a-kind co-innovation that empowers enterprises to harness the power of edge computing. The strategic partnership introduces a unique solution that seamlessly integrates Edge, Private 5G, IOT, and Modular Data Centers, providing unparalleled connectivity, and supports the computational demands of Generative AI applications deployed at the edge.
The joint offering combines NTT DATA’s Edge as a Service, which includes fully managed Edge to Cloud, Private 5G, and IoT capabilities, with Schneider Electric’s EcoStruxure, a modular data center that fuses OT solutions with the latest in IT technologies. This powerful combination enables companies to maximize energy efficiency and meet the demands of compute-intensive tasks such as machine vision, predictive maintenance, and other AI inferencing applications at the edge.
“We've listened to our customers and know that processing vast amounts of data generated by edge devices is where the future of digital transformation lies. That's why we're excited to announce that we have the solution to meet these obstacles and are ready to lead the way towards a more connected and efficient digital world. We are thrilled at the prospect of what our continued collaboration with Schneider Electric means for the industrial and other sectors,” said Shahid Ahmed, EVP New Ventures, and Innovation at NTT Ltd.
Customers can now implement a complete solution, including edge data centers tailored for digital transformation in remote and brownfield locations, where high compute demands critical infrastructure, such as power, cooling, racks, and specialized IoT and AI management systems.
The companies will go to market to address joint customer requirements to meet the growing demand from organizations who are looking to leverage edge compute to support automation and enable data-driven decision making. According to NTT DATA’s Edge Advantage report nearly 70% of enterprises are accelerating edge adoption to solve critical business challenges.
With today’s news, NTT DATA and Schneider Electric announced they are delivering the first Private 5G enabled deployment of an EcoStruxure Data Center at Marienpark Berlin. The historic site will be developed into a leading innovation park. The area spans over 30-hectare, equivalent to 74 acres, and will focus on delivering enhanced connectivity and compute experiences for users across the campus.
“Today’s innovation ecosystems in Marienpark increasingly depend on specific technological infrastructures. Easy-to-access computational power combined with advanced connectivity are a key issue. We need an innovative environment with such an infrastructure to satisfy future user demands of our community,” said Guido Schütte, Managing Director, Marienpark Berlin.
NTT DATA and Schneider Electric initially co-innovated to test the power of Private 5G at Schneider Electric’s Lexington Smart Factory, the first of Schneider Electric’s U.S. plants to become a Smart Factory showcase site leveraging Private 5G, IoT connectivity, edge analytics, and predictive analytics to drive energy efficiency and further sustainability goals.
“After leveraging NTT DATA’s expertise in Private 5G connectivity and then maximizing synergies with our EcoStruxure architecture in our facilities, it’s time to expand our collaboration and bring a complete solution to industrial customers,” said Rob McKernan, President, Cloud & Service Provider Segment at Schneider Electric. “Together, we aim to assist global clients in adopting connected devices, specialized industrial solutions, and the right edge computing infrastructure with modular Data Centers to gain valuable data insights, particularly in the context of IoT and emerging AI requirements.”
The collaboration addresses the challenges brought on by industry 4.0 applications, ensuring seamless connectivity, high bandwidth, and secure low latency connections through Edge data centers.
“Industry 4.0 relies on actionable, data-driven intelligence delivered in real time whether that be in a factory, an industrial park, an airport, or an office campus,“ said Camille Mendler, Chief Analyst, Enterprise Services, Omdia. “AI-enriched data already accounts for a third of enterprise network traffic, but it will dominate digital interactions by 2030. To profit from AI insights, enterprises must invest in digital resources at the edge, and the technology infrastructure that powers it, now.”
Innovations on Display at Mobile World Congress
NTT DATA and Schneider Electric will discuss their co-innovation partnership and demonstrate how edge and private 5G are transforming industries on February 26 between 1300 – 1400 hours at the NTT DATA booth in Hall 4 – Stand 4A20.
About NTT Ltd.
As part of NTT DATA, a USD 30 billion IT services provider, NTT Ltd. is a leading IT infrastructure and services company serving 65% of the Fortune Global 500 and more than 75% of the Fortune Global 100. We lay the foundation for organizations’ edge-to-cloud networking ecosystem, simplify the complexity of their workloads across multicloud environments, and innovate at the edge of their IT environments where networks, cloud and applications converge. We offer tailored infrastructure and ensure consistent best practices in design and operations across all of our secure, scalable and customizable data centers. On the journey towards a software-defined future, we support organizations with our platform-delivered infrastructure services. We enable a connected future.
Visit us at services.global.ntt
About Schneider Electric
Schneider Electric’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
Follow us on:
X
Facebook
LinkedIn
YouTube
Instagram
Schneider Electric Blog
Discover the newest perspectives shaping sustainability, electricity 4.0, and next-generation automation on Schneider Electric Insights.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223446791/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom